HAL, Alkem, Abbott strong in Q1; Balrampur faces H2 test
Analyst FIS' Q1 review showed HAL's revenue and profit dipped YoY but sequential rebound and ₹2.09 lakh crore order book bolster FY26 outlook. Alkem posted steady 7% revenue, 4% profit growth; Abbott delivered double-digit gains with a hefty dividend. Balrampur Chini saw flat margins, lower profit, and supply issues-making H2 crucial for recovery.